A few other quick observations:
Looking back through the last 10 years of summarised financials:
Challenger seems to have been reducing its long term debt relative to its equity base. (ie long term debt on its balance sheet has been declining whilst equity has been increasing). This negatively effects RoE but obviously makes the company less risky.
All taken from Commsec:
June 2019 BV $5.94 NTA: $4.98
Estimated 2021 EPS: $0.53
11% return on NTA, yet NTA is above current market price. And compare that to current interest rates of effectively zero.
All back of the envelope type stuff.
But as part of a diversified portfolio, and with still some cash sitting on the sidelines, I am happy acquiring more at current levels, which i did today.
Ann: Third quarter performance, page-7
Add CGF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.56 |
Change
0.000(0.00%) |
Mkt cap ! $4.535B | |||
| Open | High | Low | Value | Volume |
| $6.52 | $6.60 | $6.47 | $7.808M | 1.190M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400 | $6.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.58 | 3317 | 2 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| CGF (ASX) Chart |